Projekt
A Phase 3, Multi-Site, Open-Label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Automatisch geschlossen · 2011 bis 2015
Anliker Mark
Keine Resultate gefunden.